CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0042
+0.0011 (35.48%)
Jan 20, 2026, 3:44 PM EST
CannaPharmaRX Market Cap
CannaPharmaRX has a market cap or net worth of $3.48 million as of January 20, 2026. Its market cap has decreased by -36.14% in one year.
Market Cap
3.48M
Enterprise Value
24.13M
Revenue
1.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 29, 1999, CannaPharmaRX's market cap has decreased from 27.64M to 3.48M, a decrease of -87.41%. That is a compound annual growth rate of -7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.48M | 1.92% |
| Dec 31, 2025 | 3.41M | -35.80% |
| Dec 31, 2024 | 5.32M | 622.75% |
| Dec 29, 2023 | 735.50K | -71.38% |
| Dec 30, 2022 | 2.57M | 62.24% |
| Dec 31, 2021 | 1.58M | -92.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |